ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2022

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.

William R Strohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.